Inhaled And Intranasal Products Contract Service Providers Market Size, Share & Trends Analysis Report By Drug Delivery Product (Metered-dose inhalers, Dry powder inhalers, Nebulizers), By Services, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Inhaled And Intranasal Products Contract Service Providers market size was estimated at USD 2.9 billion in 2022 and is projected to hit around USD 4.18 billion by 2030, growing at a CAGR of 8.11% during the forecast period 2022 to 2030.

Key Takeaways:

  • By Drug Delivery Product, the U.S. Inhaled And Intranasal Products Contract Service Providers market was valued at USD 448.9 million in 2021 and expected to witness growth at a CAGR of 7.11% from 2022 to 2030.
  • Metered- dose inhalers (MDIs) segment dominated the market with a revenue share of 50.10% in 2022. This is due to the rise in their ease of use, which is often self-administered by the patient through inhalation in short bursts of a predetermined dose
  • Based on services, contract manufacturing dominated the segment with a revenue share of 54.12% in 2022. The increasing focus of manufacturers on reducing the cost of medical devices drives the growth of the market
  • Quality assurance services is anticipated to register the fastest CAGR growth of 10.9% during the forecast period
  • Asia Pacific dominated the market in 2022 with a 41.9% market share. The presence of a large number of contract manufacturers, and increasing respiratory diseases such as COPD are the key factors driving the growth of the market

There is an increased awareness of the effective and advanced respiratory devices compared to the traditional treatments fueling the growth of the market.

Inhaler design has seen little change in the past ten years, but some features have led to advancements that open new possibilities for disease treatment according to an article published by the National Library of Medicine (NIH) in 2021. The development of vibrating mesh systems for nebulizers was the most significant advancement, whereas the formulation, metering system, and aerosol dispersion properties are the three main components of dry powder inhaler technology. Furthermore, one of the most important breakthroughs at the start of the new millennium was the regulatory approval and commercialization of Advair/Seretide (GlaxoSmithKline). These developments and advancements in the design of the product improve the drug delivery system. Hence, contributing to the growth of the inhaled & intranasal products contract service providers market.

COVID-19 has resulted in a positive impact on the market. For instance, according to a July 2020 article titled "Inhalers Safe During COVID-19 Pandemic," asthma and chronic obstructive pulmonary disease patients are usually prescribed inhaled and oral corticosteroids along with inhalers to avoid attacks. Inhaler shortages occurred in the U.K. as a result of a 400% increase in demand during the pandemic. The U.K.’s population was attempting to stock up in anticipation of the COVID-19 pandemic, according to the Department of Health and Social Care, which resulted in distressing shortages. As a result, during the pandemic phase, such incidences increased the demand for the market.

Drug delivery products such as nebulizers are in high demand owing to the significant usage of nebulizers in hospitals and home care settings. The increasing launch of the latest technology-based nebulizers such as jet nebulizers is one of the major factors propelling the demand for market. Nebulizers are products that combine drugs and devices. As a result, the aerosol characteristics, targeting, and efficacy are directly influenced by the interactions between the inhaled formulation and the nebulizer device. Nebulizers generate the aerosol independently of the patient's force of inspiration. As a result, they are successfully applied to specific patient populations, including newborns, children, the elderly, and those with advanced lung illness.

Report Scope of the Inhaled And Intranasal Products Contract Service Providers Market

Report Coverage

Details

Market Size

USD 4.18 Billion by 2030

Growth Rate

CAGR of 8.11% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Drug delivery product, services, and Region,

Companies Mentioned

Lonza; Catalent Inc. ; Kindeva Drug Delivery; Recipharm; Quotient Services; Hovione; Colep; Beximo Pharmaceuticals; DPT Laboratories; Orion

 

Drug Delivery Product Insights

Metered-dose inhalers (MDIs) accounted for the largest market share of 50.10% in 2022. It is also projected to register the fastest CAGR growth of 8.9% during the forecast period. It  is typically used to treat respiratory conditions including COPD and asthma. They are portable, pocket-sized medicine delivery systems that generate aerosols using compressed propellants. Also, there is no requirement for drug preparation, and also the dose-dose reproducibility is also high. Examples of metered dose inhalers include atrovent inhalers, salamol inhalers, and Flixotide inhaler.

Dry Powder Inhalers accounted for the second-highest market share of 27.9% in 2022. It is a type of inhaler widely used to deliver the drug into the lungs, such as inhaled corticosteroids. DPIs have the potential to be efficient and simple to use, and they do not require expensive and hazardous propellants like CFCs that can pollute the environment. They can be single, multiple unit dosage, or multi-dose, with the latter requiring a bulk container and a suitable powder measuring method that the patient needs to use. DPIs can administer far larger doses than MDIs. Examples of dry powder inhalers include Advair Diskus, Asmanex, and Pulmicort flexhaler.

Services Insights

Contract manufacturing accounted for the maximum revenue share of 54.12% in 2022. The focus of manufacturers on lowering the cost of medical devices and the complexity of manufacturing have significantly boosted the demand for outsourcing services, which has driven the growth of the market. Furthermore, companies are using shift work to save fixed costs. Additionally, small and medium-sized companies lack the technical resources and skilled labor to complete the task. The above problems can be resolved by contract manufacturing.

  • Product Maintenance
  • Contract Manufacturing

Quality Assurance Services is anticipated to register the fastest growth of CAGR 10.8% during the forecast period. Quality assurance services include strategy, implementation, quality system assessments, and identification of quality metrics to ensure continuous improvement. It is performed regularly throughout the manufacturing process and is frequently done by a team of individuals. Maintenance of an effective quality management system is an integral part of the production of every medical device. One such quality management system is ISO 13485 which involves the development, implementation, and maintenance of products intended for use by medical device manufacturers and suppliers. Hence, these regulatory factors contribute to the growth of the market.

Regional Insights

Asia Pacific accounted for the largest market share of 41.8% in 2022. The presence of a large population base, increasing government support, and rising incidence of respiratory disorders are the key factors driving the growth of the market in the region. For instance, according to an article published in 2021 by the National Library of Medicine (NIH) the prevalence of COPD in the Asia-Pacific countries are as follows 5.6% in Indonesia, 14.5% in Australia, 6.7% in China, 8.6% in Japan and 13.4% in Korea.

North America accounted to be the second highest market share of 24.9% for the market. This is due to ease of regulatory compliance, the presence of a large number of contract manufacturers, and increasing respiratory diseases such as COPD. For instance, according to research by the centers for disease control and prevention (CDC), COPD affected over 15 million people in the U.S. in 2021.

Some of the prominent players in the Inhaled And Intranasal Products Contract Service Providers Market include:

  • Lonza
  • Catalent Inc.
  • Kindeva Drug Delivery
  • Recipharm
  • Quotient Services
  • Hovione
  • Colep
  • Beximo Pharmaceuticals
  • DPT Laboratories
  • Orion

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Inhaled And Intranasal Products Contract Service Providers market

  • Drug Delivery Product)
    • Metered - dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
    • Others
  • Services
    • Quality Assurance
    • Regulatory Affair Services
    • Product Design & Development
    • Product Testing & Sterilization
    • Product Implementation
    • Product Upgrade
    • Product Maintenance
    • Contract Manufacturing

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Inhaled And Intranasal Products Contract Service Providers industry analysis from 2022 to 2030 to identify the prevailing Inhaled And Intranasal Products Contract Service Providers industry opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the global Inhaled And Intranasal Products Contract Service Providers industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global Inhaled And Intranasal Products Contract Service Providers industry trends, key players, market segments, application areas, and market growth strategies.

Report Detail

  • Report Code:7558
  • No. of Pages:150+
  • Format:PDF/PPT/Excel

Proceed To Buy

USD 3500
USD 7000